Soberlink Within In-Home Addiction Treatment Program

In-Home Addiction Treatment Institute, Inc.

Status

Unknown

Conditions

Alcohol Use Disorder

Treatments

Device: Soberlink

Study type

Observational

Funder types

Other

Industry

Identifiers

NCT03902171

SLIHAT-2019

Details and patient eligibility

About

The purpose of this study is to evaluate the impact of use of Soberlink on treatment experience for individuals with alcohol use disorder while enrolled in an In-Home Addiction Treatment program. Treatment engagement, feelings related to autonomy and empowerment, and overall quality of life will be evaluated. Although not the primary focus, recidivism and relapse will be measured.

Full description

The study will include 30 Clients with a primary or secondary diagnosis of alcohol use disorder (AUD) and who are enrolled in Aware Recovery Care's In-Home Addiction Treatment program where Care Teams will monitor cloud-based breathalyzer results. Soberlink's cloud-based breathalyzer system will provide data to Care Team if the Client has relapsed or is not compliant with testing through the Soberlink System. Clients will use Soberlink for 180 days within context of routine alcohol use disorder treatment at Aware Recovery Care.

Enrollment

30 estimated patients

Sex

All

Ages

21 to 75 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

Male or female subject between ages of 21-75 years old
Subject active in In-Home Addiction Treatment Program (Aware Recovery Care)
Subject admitted to program with American Society of Addiction Medicine (ASAM) Assessment score 1.5-2.5
Primary or secondary diagnosis is alcohol use disorder
Subject is willing to use Soberlink Device to provide Blood Alcohol Content (BAC)
Subject is willing to discuss Soberlink test results with Care Team
Subject is willing to sign Soberlink Client Agreement
Subject is English speaking and reading

Exclusion criteria

Alcohol use disorder is not a primary or secondary diagnosis
Subject is not between ages of 21 and 75 years old
Subject is currently taking anti-alcohol/craving medications (Antabuse, Campral, Vivitrol)
Subject will not be in the United States through duration of study
Subject is unwilling to properly use the device
Subject is non-English speaking and reading
Subject is a child, adolescent, cognitively impaired, diagnosed with a mental disorder involving depersonalization or active psychotic symptoms
Active withdrawal/alcohol use within 72 hours of start of participation
Subject is using Soberlink data for a child custody or legal consequence